Hantz Financial Services’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.67M Buy
33,749
+31,357
+1,311% +$2.67M 0.04% 292
2026
Q1
$206K Sell
2,392
-382
-14% -$34.3K ﹤0.01% 981
2025
Q4
$242K Buy
2,774
+2,325
+518% +$176K ﹤0.01% 800
2025
Q3
$26K Buy
449
+96
+27% +$5.53K ﹤0.01% 1474
2025
Q2
$21K Buy
353
+219
+163% +$14.1K ﹤0.01% 1247
2025
Q1
$10K Buy
+134
New +$11.1K ﹤0.01% 959
2024
Q2
Sell
-25
Closed -$1K 1137
2024
Q1
$1K Hold
25
﹤0.01% 1122
2023
Q4
$1K Hold
25
﹤0.01% 1075
2023
Q3
$1K Sell
25
-114
-82% -$6.38K ﹤0.01% 1070
2023
Q2
$8K Hold
139
﹤0.01% 807
2023
Q1
$8K Hold
139
﹤0.01% 811
2022
Q4
$10K Buy
139
+114
+456% +$7.76K ﹤0.01% 751
2022
Q3
$1K Hold
25
﹤0.01% 1014
2022
Q2
$1K Hold
25
﹤0.01% 992
2022
Q1
$2K Buy
+25
New +$1.74K ﹤0.01% 955

Other funds holding GMED

Hantz Financial Services's GMED Position: Q2 2026 in Review

Hantz Financial Services increased its Globus Medical (GMED) stake by 1,311% in Q2 2026, buying an estimated $2.67M and bringing the position to 33,749 shares worth $2.67M. The position accounts for 0.04% of the portfolio, ranked #292.

Hantz Financial Services first reported a position in GMED in Q1 2022 and has held it in 15 quarters since. 599 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Hantz Financial Services held 33,749 shares of Globus Medical worth $2.67M as of Q2 2026.
  • Hantz Financial Services bought 31,357 Globus Medical shares in Q2 2026, an estimated $2.67M.
  • Globus Medical made up 0.04% of Hantz Financial Services's portfolio in Q2 2026, its #292 holding.
  • Hantz Financial Services first reported a position in Globus Medical in Q1 2022 and has held it in 15 quarters since.
  • 599 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Hantz Financial Services's 13F filing for Q2 2026, filed 13 Aug 2026.